Elevance Health, Inc.
ELV
$289.10
$8.673.09%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.66% | 4.81% | 1.06% | 1.45% | 1.51% |
| Total Other Revenue | 13.02% | 16.31% | 14.75% | 12.92% | 15.90% |
| Total Revenue | 10.21% | 6.63% | 3.19% | 3.20% | 3.62% |
| Cost of Revenue | 12.52% | 6.64% | 2.60% | 1.79% | 0.86% |
| Gross Profit | 4.37% | 6.58% | 4.75% | 7.00% | 11.33% |
| SG&A Expenses | 10.79% | 11.92% | 8.91% | 4.66% | 11.49% |
| Depreciation & Amortization | -14.57% | -19.19% | -34.46% | -32.57% | -23.81% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.00% | 7.72% | 3.82% | 2.24% | 2.99% |
| Operating Income | -17.12% | -10.65% | -7.00% | 20.59% | 14.28% |
| Income Before Tax | -17.62% | -3.40% | 2.45% | 6.96% | 4.23% |
| Income Tax Expenses | -9.48% | 3.17% | 12.12% | 10.92% | 0.11% |
| Earnings from Continuing Operations | -19.94% | -5.29% | -0.33% | 5.83% | 5.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.00% | 37.50% | 325.00% | 170.73% | 140.00% |
| Net Income | -19.89% | -5.24% | -0.12% | 7.04% | 6.04% |
| EBIT | -17.12% | -10.65% | -7.00% | 20.59% | 14.28% |
| EBITDA | -15.27% | -10.71% | -8.97% | 13.56% | 9.19% |
| EPS Basic | -17.77% | -3.21% | 1.71% | 9.10% | 8.25% |
| Normalized Basic EPS | -19.68% | -12.33% | -7.69% | 25.79% | 17.67% |
| EPS Diluted | -17.61% | -3.14% | 1.74% | 9.17% | 8.46% |
| Normalized Diluted EPS | -19.59% | -12.32% | -7.71% | 25.96% | 17.99% |
| Average Basic Shares Outstanding | -2.29% | -2.00% | -1.84% | -1.90% | -1.98% |
| Average Diluted Shares Outstanding | -2.42% | -2.07% | -1.90% | -1.96% | -2.19% |
| Dividend Per Share | 7.40% | 8.73% | 10.14% | 11.36% | 12.68% |
| Payout Ratio | 0.31% | 0.12% | 0.08% | 0.02% | 0.04% |